Akèy › Neurofibrosarkòm › Washington
Etid klinik pou Neurofibrosarkòm nan Washington, DC
6 etid pou Neurofibrosarkòm ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
SPEARHEAD-3 Pediatric Study
Ap rekriteFaz 1/2
- National Institutes of Health, Bethesda · 7 mi lwen
Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
Ap rekriteFaz 1/2
- Children's National Hospital, Washington D.C.
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Ap rekriteFaz 2
- Children's National Hospital (Data Collection Only), Washington D.C.
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Ap rekriteEtid obsèvasyon
- National Institutes of Health (NIH), Bethesda · 7 mi lwen
Etid Neurofibrosarkòm nan lòt vil
- New York City, NY6 etid
- St. Louis, MO4 etid
- Boston, MA4 etid
- Mountain View, CA3 etid
- Cincinnati, OH3 etid
- Houston, TX3 etid
- Chicago, IL3 etid
- Edison, NJ3 etid
- Queens, NY3 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.